Menu

Bones Get in Her Eyes

After undergoing untested cosmetic surgery that uses stem cells to rejuvenate skin, a woman grew bone fragments in the flesh around one of her eyes.

Dec 20, 2012
Dan Cossins

WIKIMEDIA, 8THSTARA Los Angeles woman who opted for an face-lift procedure involving adult stem cells ended up with fragments of bone embedded around her right eye, which made strange clicking noises and caused considerable pain. Reported this week in Scientific American, the case highlights the dangers of the untested stem cell-based cosmetic procedures that are becoming increasingly common in clinics around the United States.

The woman underwent the $20,000 surgery at a clinic in Beverley Hills in 2009. Surgeons isolated mesenchymal stem cells from her abdominal fat—cells that can become bone, cartilage, and fat, among other types of tissue—before injecting them into the skin around her eyes. The plan was that the stem cells would rejuvenate the skin by transforming into new skin tissue and releasing chemicals that stimulate other skin cells to proliferate.

But the surgeons also injected dermal filler, commonly used to reduce wrinkles. These fillers are made up largely of calcium hydroxylapatite, a mineral used by cell biologists to coax mesenchymal stem cells to become bone. This interaction likely resulted in the development of little pieces of bone in flesh around the woman’s eyes, the surgeon who three months later removed the fragments told Scientific American.

More and more clinics are now offering untested stem cell treatments for a range of cosmetic and medical procedures, and the overstretched US Food and Drug Administration is struggling to clamp down on all of them. Unapproved therapies are dangerous for consumers, and they could also make it more difficult for legitimate stem cell researchers to get funding as unscrupulous private clinics stigmatize the field.  

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.